NoGeneST™ APP-ASO, Antisense Oligonucleotide

Name: NoGeneST™ APP-ASO, Antisense Oligonucleotide
SKU: NRYF-0625-XY69
Rating: 5 (1 reviews)

[CAT#: NRYF-0625-XY69]

Target:: APP

Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

Inquiry

Product Overview

Description

APP-ASO is an antisense oligonucleotide designed to reduce amyloid-β aggregation.

Species

Human

Applications

Specifically targets APP mRNA to reduce amyloid-β (Aβ) production in Alzheimer's disease (AD) research. Enables investigation of APP's role in neuronal plasticity, Aβ aggregation, and tau phosphorylation. Suitable for in vitro (primary neuronal cultures) and in vivo (AD transgenic mouse models) studies to validate APP as a therapeutic target for Aβ-related neurodegeneration.

Relevant Diseases

Alzheimer disease

Properties

Appearance

Solid

Shipping

Room temperature

Storage

Store at -20°C, sealed and away from moisture.
In solvent, store at -80°C for up to 6 months, or -20°C for up to 1 month (sealed and away from moisture).

Research Use Only

For research use only.

Target Details

Target

APP

Official Name

APP

Full Name

Amyloid Beta Precursor Protein

Alternative Names

Alpha-SAPP; AD1; Alzheimer Disease Amyloid A4 Protein Homolog; Amyloid Beta (A4) Precursor Protein; Alzheimer Disease Amyloid Protein; Cerebral Vascular Amyloid Peptide

Publications